Literature DB >> 17828751

Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats.

Zhenling Yao1, Debra C DuBois, Richard R Almon, William J Jusko.   

Abstract

Adrenal suppression and lymphocytopenia are commonly monitored pharmacological responses during systemic exposure to exogenously administered corticosteroids. The pharmacodynamics of plasma corticosterone (CS) and blood lymphocytes were investigated in 60 normal rats which received either 50 mg/kg methylprednisolone (MPL) or vehicle intramuscularly. Blood samples were collected between 0.5 and 96 h following treatment. Plasma CS displayed a transient suppression with re-establishment of a normal circadian rhythm 24 h following drug treatment. An indirect response model with suppression of production well captured plasma CS profiles. An early stress-induced rise in CS was also factored into the model. Blood lymphocyte numbers exhibited a sharp decline and then returned to a new circadian rhythm which was half of the original baseline level. An integrated pharmacodynamic (PD) model with inhibition of lymphocyte trafficking from tissue to blood by both MPL and CS and induction of cell apoptosis by MPL reasonably captured this lymphocytopenia. Rats and humans differ in lymphocyte responses with humans showing full recovery of baselines. Modeling provides a valuable tool in quantitative assessment of dual, complex drug responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17828751      PMCID: PMC3726057          DOI: 10.1002/jps.21167

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  33 in total

1.  Inhaled beclomethasone dipropionate downregulates CD4 and CD8 T-lymphocyte activation in peripheral blood of patients with asthma.

Authors:  M Majori; M L Piccoli; S Bertacco; A Cuomo; L Cantini; A Pesci
Journal:  J Allergy Clin Immunol       Date:  1997-09       Impact factor: 10.793

2.  Oral budesonide for lymphocytic colitis.

Authors:  A Van Gossum; A Schmit; M O Peny
Journal:  Am J Gastroenterol       Date:  1998-02       Impact factor: 10.864

3.  Pharmacodynamic modeling of prednisolone effects on natural killer cell trafficking.

Authors:  Z X Xu; M J Lee; R A Blum; W J Jusko
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

Review 4.  Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates.

Authors:  D T Boumpas; G P Chrousos; R L Wilder; T R Cupps; J E Balow
Journal:  Ann Intern Med       Date:  1993-12-15       Impact factor: 25.391

Review 5.  Glucocorticoid-induced apoptosis of lymphoid cells.

Authors:  R A Schwartzman; J A Cidlowski
Journal:  Int Arch Allergy Immunol       Date:  1994-12       Impact factor: 2.749

6.  Environmental, age, and sex effects on cotton rat (Sigmodon hispidus) hematology.

Authors:  G L Robel; R L Lochmiller; S T McMurry; C W Qualls
Journal:  J Wildl Dis       Date:  1996-04       Impact factor: 1.535

7.  In vivo resistance to glucocorticoid-induced apoptosis in rat thymocytes with normal steroid receptor function in vitro.

Authors:  N B Oldenburg; R B Evans-Storms; J A Cidlowski
Journal:  Endocrinology       Date:  1997-02       Impact factor: 4.736

8.  Effect of high-dose methylprednisolone and G-CSF treatments on lymphocyte subtypes in neutropenic children with acute lymphoblastic leukemia: a pilot study.

Authors:  N Ozbek; S Yetgin; A M Tuncer
Journal:  Pediatr Hematol Oncol       Date:  1998 Nov-Dec       Impact factor: 1.969

9.  A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1.

Authors:  B N Cronstein; S C Kimmel; R I Levin; F Martiniuk; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

10.  Apoptosis of T cells and macrophages in the central nervous system of intact and adrenalectomized Lewis rats during experimental allergic encephalomyelitis.

Authors:  T Smith; M Schmied; A K Hewson; H Lassmann; M L Cuzner
Journal:  J Autoimmun       Date:  1996-04       Impact factor: 7.094

View more
  18 in total

1.  Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran; Debra C DuBois; Richard R Almon; Jun Qu; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-27       Impact factor: 2.745

2.  Modeling the Effect of the Selective S1P1 Receptor Modulator Ponesimod on Subsets of Blood Lymphocytes.

Authors:  Dominik Lott; Andreas Krause; Christian A Seemayer; Daniel S Strasser; Jasper Dingemanse; Thorsten Lehr
Journal:  Pharm Res       Date:  2016-12-27       Impact factor: 4.200

3.  Pharmacokinetic/pharmacodynamic modeling of methylprednisolone effects on iNOS mRNA expression and nitric oxide during LPS-induced inflammation in rats.

Authors:  Siddharth Sukumaran; Eve-Irene Lepist; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

Review 4.  Pharmacokinetic/pharmacodynamic modeling in inflammation.

Authors:  Hoi-Kei Lon; Dongyang Liu; William J Jusko
Journal:  Crit Rev Biomed Eng       Date:  2012

5.  Modeling disease progression and rosiglitazone intervention in type 2 diabetic Goto-Kakizaki rats.

Authors:  Wei Gao; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2012-02-29       Impact factor: 4.030

6.  Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression.

Authors:  Vivaswath S Ayyar; Debra C DuBois; Toshimichi Nakamura; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2019-06-13       Impact factor: 4.030

Review 7.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

8.  Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part III: Estrous Cycle and Estrogen Receptor-Dependent Antagonism of Glucocorticoid-Induced Leucine Zipper (GILZ) Enhancement by Corticosteroids.

Authors:  Vivaswath S Ayyar; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2019-06-13       Impact factor: 4.030

9.  Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.

Authors:  Vivaswath S Ayyar; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2017-07-20       Impact factor: 4.030

10.  Different stress-related phenotypes of BALB/c mice from in-house or vendor: alterations of the sympathetic and HPA axis responsiveness.

Authors:  Jakob Olfe; Grazyna Domanska; Christine Schuett; Cornelia Kiank
Journal:  BMC Physiol       Date:  2010-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.